Search research articles
Contact Us
Filters
Showing results (41-50 of 544) with videos related to
Page
of 55
Sort By:
Genetic Testing
|
March 21, 2006
A fluorescent multiplex-DGGE screening test for mutations in the BRCA1 gene
Graciela Kuperstein, Elaine Jack, Steven A Narod
Breast Cancer Research : BCR
|
November 11, 2005
A common missense variant in BRCA2 predisposes to early onset breast cancer
Bohdan Górski, Steven A Narod, Jan Lubinski
Breast Cancer Research and Treatment
|
February 16, 2018
A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis
Vasily Giannakeas, Victoria Sopik, Steven A Narod
Familial Cancer
|
May 20, 2014
Genetics of endometrial cancer
Ayelet Shai, Yakir Segev, Steven A Narod
Women'S Health (London, England)
|
September 1, 2012
BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations
Amy Finch, Gareth Evans, Steven A Narod
International Journal of Cancer
|
June 20, 2014
Multiple primary cancers as a guide to heritability
Cezary Cybulski, Safia Nazarali, Steven A Narod
Nature Protocols
|
April 5, 2007
Mutation screening using fluorescence multiplex denaturing gradient gel electrophoresis (FMD): detecting mutations in the BRCA1 gene
Shiyu Zhang, Graciela Kuperstein, Steven A Narod
Breast Cancer Research and Treatment
|
November 10, 2017
Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ
Victoria Sopik, Ping Sun, Steven A Narod
Breast Cancer Research and Treatment
|
April 5, 2017
Which women decide to take tamoxifen?
Steven A Narod, Victoria Sopik, Ping Sun
Breast Cancer Research and Treatment
|
October 27, 2016
Can we prevent BRCA1-associated breast cancer by RANKL inhibition?
Joanne Kotsopoulos, Christian Singer, Steven A Narod
Page
of 55
Search research articles
Search
Showing results (41-50 of 544) with videos related to
Sort By:
Page
of 55
Genetic Testing
|
March 21, 2006
A fluorescent multiplex-DGGE screening test for mutations in the BRCA1 gene
Graciela Kuperstein, Elaine Jack, Steven A Narod
Breast Cancer Research : BCR
|
November 11, 2005
A common missense variant in BRCA2 predisposes to early onset breast cancer
Bohdan Górski, Steven A Narod, Jan Lubinski
Breast Cancer Research and Treatment
|
February 16, 2018
A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis
Vasily Giannakeas, Victoria Sopik, Steven A Narod
Familial Cancer
|
May 20, 2014
Genetics of endometrial cancer
Ayelet Shai, Yakir Segev, Steven A Narod
Women'S Health (London, England)
|
September 1, 2012
BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations
Amy Finch, Gareth Evans, Steven A Narod
International Journal of Cancer
|
June 20, 2014
Multiple primary cancers as a guide to heritability
Cezary Cybulski, Safia Nazarali, Steven A Narod
Nature Protocols
|
April 5, 2007
Mutation screening using fluorescence multiplex denaturing gradient gel electrophoresis (FMD): detecting mutations in the BRCA1 gene
Shiyu Zhang, Graciela Kuperstein, Steven A Narod
Breast Cancer Research and Treatment
|
November 10, 2017
Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ
Victoria Sopik, Ping Sun, Steven A Narod
Breast Cancer Research and Treatment
|
April 5, 2017
Which women decide to take tamoxifen?
Steven A Narod, Victoria Sopik, Ping Sun
Breast Cancer Research and Treatment
|
October 27, 2016
Can we prevent BRCA1-associated breast cancer by RANKL inhibition?
Joanne Kotsopoulos, Christian Singer, Steven A Narod
Page
of 55